Solara Active Pharma Sciences Ltd
SOLARASolara Active Pharma Sciences Ltd
SOLARA
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -8.26 | 4.73 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
SSL Pharma Sciences is a manufacturer of pharmaceutical preparation
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 523.43 | 1,399.06 | 1,349.27 | 1,645.65 | 1,288.36 | 1,466.36 | 1,294.29 | 1,261.63 | ||||||||
Raw Materials | 274.29 | 738.62 | 653.03 | 726.57 | 912.64 | 781.78 | 765.75 | 1,492.25 | ||||||||
| Power & Fuel Cost | 31.41 | 79.35 | 77.68 | 85.42 | 93.70 | 108.10 | 122.56 | |||||||||
| Employee Cost | 68.53 | 185.81 | 204.13 | 229.37 | 236.34 | 228.63 | 243.92 | |||||||||
| Selling & Administrative Expenses | 22.66 | 64.48 | 69.23 | 73.77 | 74.60 | 66.93 | 70.53 | |||||||||
| Operating & Other expenses | 67.23 | 105.29 | 58.24 | 115.88 | -125.42 | 124.49 | 371.51 | |||||||||
EBITDA | 59.31 | 225.51 | 286.96 | 414.64 | 96.50 | 156.43 | -279.98 | -230.62 | ||||||||
| Depreciation/Amortization | 33.98 | 83.10 | 94.16 | 108.66 | 112.32 | 111.19 | 103.33 | 101.62 | ||||||||
| PBIT | 25.33 | 142.41 | 192.80 | 305.98 | -15.82 | 45.24 | -383.31 | -332.24 | ||||||||
| Interest & Other Items | 25.14 | 82.42 | 77.89 | 84.48 | 75.28 | 90.06 | 105.11 | 115.21 | ||||||||
| PBT | 0.19 | 59.99 | 114.91 | 221.50 | -91.10 | -44.82 | -488.42 | -447.45 | ||||||||
| Taxes & Other Items | -0.18 | 0.48 | 0.30 | 0.10 | -32.95 | -22.64 | 78.97 | 88.68 | ||||||||
| Net Income | 0.37 | 59.51 | 114.61 | 221.40 | -58.15 | -22.18 | -567.39 | -536.13 | ||||||||
| EPS | 0.14 | 21.74 | 40.14 | 65.00 | -14.90 | -5.68 | -145.27 | -137.27 | ||||||||
| DPS | 0.00 | 4.61 | 1.84 | 6.45 | 0.00 | 2.76 | 0.00 | 0.00 | ||||||||
| Payout ratio | 0.00 | 0.21 | 0.05 | 0.10 | 0.00 | — | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Solara Active Pharma Sciences Ltd | -7.81 | 4.73 | — |
| Sun Pharmaceutical Industries Ltd | 45.34 | 6.47 | 0.75% |
| Cipla Ltd | 31.21 | 4.80 | 0.82% |
| Torrent Pharmaceuticals Ltd | 65.38 | 15.80 | 0.88% |
Price Comparison
Compare SOLARA with any stock or ETFShareholdings
Promoter Holdings Trend
Increased Total Promoter Holding
In last 6 months, promoter holding in the company has increased by 6.78%
High Pledged Promoter Holding
A significant proportion of promoter holdings is pledged
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.51%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 4 Mutual Funds holding Solara Active Pharma Sciences Ltd
| Funds (Top 4) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Aditya Birla Sun Life Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7311% | Percentage of the fund’s portfolio invested in the stock 0.14% | Change in the portfolio weight of the stock over the last 3 months 0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 84/89 (-7) |
Aditya Birla Sun Life Midcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2263% | Percentage of the fund’s portfolio invested in the stock 0.16% | Change in the portfolio weight of the stock over the last 3 months 0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 92/96 (-4) |
Aditya Birla Sun Life Manufacturing Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1131% | Percentage of the fund’s portfolio invested in the stock 0.41% | Change in the portfolio weight of the stock over the last 3 months 0.09% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 31/71 (0) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 18, 2021
Dividend/Share
₹3.00
Ex DateEx Date
Aug 18, 2021
Cash Dividend
Ex DateEx DateNov 19, 2020
Dividend/Share
₹4.00
Ex DateEx Date
Nov 19, 2020
Cash Dividend
Ex DateEx DateJul 28, 2020
Dividend/Share
₹2.00
Ex DateEx Date
Jul 28, 2020
Cash Dividend
Ex DateEx DateAug 6, 2019
Dividend/Share
₹5.00
Ex DateEx Date
Aug 6, 2019
Net profit of Solara Active Pharma Sciences reported to Rs 8.01 crore in the quarter ended September 2024 as against net loss of Rs 17.16 crore during the previous quarter ended September 2023. Sales declined 18.41% to Rs 346.95 crore in the quarter ended September 2024 as against Rs 425.24 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales346.95425.24 -18 OPM %17.678.85 - PBDT33.3514.37 132 PBT8.01-11.84 LP NP8.01-17.16 LP Powered by Capital Market - Live
Solara Active Pharma Sciences has allotted 49,000 equity shares under ESOP on 21 October 2024. Powered by Capital Market - Live
Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company on 21 October 2024.Powered by Capital Market - Live
Solara Active Pharma Sciences announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
Solara Active Pharma Sciences reports consolidated net loss of Rs 13.46 crore in the June 2024 quarter
Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company on 22 July 2024.Powered by Capital Market - Live
Solara Active Pharma Sciences closes its rights issue for raising Rs 449.95 cr
Solara Active Pharma Sciences gain on USFDA all-clear for Cuddalore unit
Solara Active Pharma Science gains on board nod to raising up to Rs 450 crore
Solara Active Pharma spurts 9% on heavy volumes
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -1.54%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.64% to 0.34%